Our pathologists have extensive expertise in scoring a wide range of diagnostic assays in the context of clinical trials and biomarker testing. Pathologists receive regular training in both novel and approved scoring methods from the developers of companion diagnostics. In addition, the global team is part of an internal pathology quality program which delivers training, skills sharing and scoring alignment across our global pathology network.

Working in tight collaboration with the team of pathologists our team of imaging scientists consists of highly educated specialists with training in digital pathology, digital imaging, algorithm development, AI, FISH enumeration, and more.

Mark Kockx, MD, PhD

Chief Medical & Scientific Officer

Mark Kockx, MD, PhD

Dr. Mark Kockx founded HistoGeneX Laboratories in 2001. At the University of Antwerp, Belgium, Dr. Kockx pioneered methodologies to elucidate apoptotic and cytostatic response of cancer patients after treatments with targeted therapies. His subsequent collaborations with global pharmaceutical companies led to the founding of HistoGeneX Laboratories.

Dr. Kockx is an internationally recognized pathologist-scientist who has operated on the forefront of personalized medicine developments. He continues to lead initiatives to standardize biomarker analysis practices in addition to adapting novel technologies. Dr. Kockx has been extensively involved with the clinical trials that led to the approval of well-known targeted therapies such as EGFR, BRAF and MEK inhibitors. His current passions are twofold. He is introducing practices and workflows for next generation IHC, combining innovations of multiplex staining, quantification and image capture. He has also developed an Immunomics program, a state-of-the-art biomarker program that supports the evolving and numerous needs of immunotherapy development.

Joanna Askren, MD

Joanna Askren, MD

Dr. Askren is a pathologist board certified in forensic, anatomic, and clinical pathology. Dr. Askren’s previous experience includes being a Forensic Pathologist for the Riverside County Sheriff’s Department. Dr. Askren received her undergraduate degree in Biomedical Sciences from the University of California, Riverside. She graduated from the biomedical sciences program with an M.D. degree from UCLA. She did a year of family medicine internship at Kaiser Permanente in Fontana. She completed her pathology residency at USC and her forensic pathology fellowship at the Los Angeles Department of Coroner. After leaving forensic pathology, she completed a surgical pathology fellowship at Olive View – UCLA Medical Center.

Konstantinos Avraam, MD, PhD

Konstantinos Avraam, MD, PhD

Dr. Avraam is a surgical pathologist from Greece who currently works in CellCarta’s pathology department. Dr. Avraam attended the Aristotle University of Thessaloniki (Greece) where he earned his medical degree in 2004 and received his title of certified pathologist in Athens (Greece) in 2011. He obtained his PhD from the National and Kapodistrian University of Athens in 2012. Dr. Avraam received his postgraduate training in dermatopathology in 2016 at the Evangelismos Hospital in Athens where he also completed his residency in Anatomic Pathology. His areas of expertise include oncopathology examining samples from the gastrointestinal, gynecological and central nervous system and mainly from skin tumors especially melanoma Dr. Avraam previously worked as a military doctor in the Department of Pathology in the 251 Hellenic Air Force hospital where he examined thousands of biopsy slides of different organs.

Hassina Djedaimi, MD

Hassina Djedaimi, MD

Dr. Djedaimi has been a recognized pathologist since 2015 and currently works in CellCarta’s pathology department. She has a strong background in skin and gynecological pathology. Previously, she worked in UZ Brussel where she examined thousands of slides of breast and digestive pathology and regularly performed autopsies.

Al Zubi Fouad, MD

Al Zubi Fouad, MD

Dr. Fouad is an anatomic pathologist from Syria, working in CellCarta’s clinical pathology department since November 2017. His areas of expertise include oncopathology, ENT pathology and hematopathology. Dr. Fouad previously worked from 2015-2017 in the UCL Saint-Luc University Hospital in Brussels. He also has previous experience as chief of pathology in Saudi Arabia and assistant pathologist in Brugmann University Hospital in Brussels.

Ramses Forsyth, MD

Ruben Gamez, MD

Ruben Gamez, MD

Dr. Gamez is board certified in hematopathology, anatomic and clinical pathology. Dr. Gamez’s previous experience includes Staff Hematopathologist and Assistant Laboratory Director for Plus Diagnostics, Staff Hematopathologist and Co-Laboratory Director at Specialty Laboratories, and Staff Pathologist at Georgetown University Hospital. Dr. Gamez obtained both his undergraduate degree and M.D. from the University of Arizona. He completed his pathology residency at the St. Joseph’s Hospital (Phoenix, AZ), with additional fellowship training in hematopathology at Georgetown University Hospital and a Donald West King fellowship at the Armed Forces Institute of Pathology (AFIP) in pulmonary pathology. Dr. Gamez also performed a rotation in lymph node pathology at the National Institute of Health /National Cancer Institute (NIH/NCI) under Dr. Elaine Jaffe.

Alfred Garcia, MD

Alfred Garcia, MD

Dr. Garcia is board certified in anatomic and clinical pathology. Prior to joining CellCarta, Dr. Garcia has worked as a Pathologist at BioPath Medical Group/Fountain Valley Regional Hospital, Foothill Regional Medical Center, Thousand Oaks Pathology Associates Diagnostics/Los Robles Medical Center, and the Alzheimer’s Disease Research Center at USC. Dr. Garcia obtained his undergraduate degree in Biological Sciences at UC Irvine, and his Medical Degree at USC’s Keck School of Medicine. He completed his anatomic and clinical pathology residency training and fellowships in surgical pathology and cytopathology at LA County/USC Medical Center.

Carlos Garcia, MD

Carlos Garcia, MD

Thomas Gevaert, MD, PhD

Miriam Marichal, MD, PhD

Miriam Marichal, MD, PhD

Dr. Marichal has been with CellCarta since 2016 and is emeritus Professor of Pathology at Free Brussels University (VUB) and former Head of the Department of Pathology at VUB-University Hospital. During her academic career, she was responsible for the courses in General and in Surgical Pathology to graduate medical and biomedical students and for the postgraduate training of residents in pathology. Dr. Marichal has published several articles in the fields of pathology, diabetes, islet cells and transplantation. She has a particular interest in endocrine-, gastrointestinal- and uro-pathology. Dr. Marichal has served many years in the Executive Committee of the European Society of Pathology.

Emil Nakov, MD

Emil Nakov, MD

Dr. Nakov works in CellCarta’s clinical pathology department. His area of expertise is in oncopathology, examining samples from the breast, the lung, and the urogenital and gastrointestinal systems. He also specializes in neuroendocrine pathology. Previously, Dr. Nakov previously worked in the Department of Clinical Pathology in the Military Medical Academy of Bulgaria. He has examined thousands of biopsy and cytology slides and regularly performed intraoperative express examinations and autopsies.

TuDung Nguyen, MD, PhD

TuDung Nguyen, MD, PhD

Dr. Nguyen is an anatomic pathologist, hematopathologist and molecular pathologist who is board certified in anatomic pathology, hematopathology and molecular pathology. She received her B.S. at UC Irvine and completed a combined M.D./Ph.D. program at the USC Keck School of Medicine where she obtained her medical degree and doctorate in Biochemistry/Molecular Biology. She completed residency in Anatomic Pathology and fellowships in Surgical Pathology, Hematopathology and Molecular Genetic Pathology at Stanford University. She previously worked as a faculty member at Washington University School of Medicine where she also served as the Associate Director of the fluorescence in situ hybridization (FISH) laboratory and Program Director of the Hematopathology Fellowship; a Hematopathologist at Genzyme Genetics and CSI Laboratories; and the Medical Director of Cancer Genetics Inc. and Oncogene Diagnostics. She has 25+ years of cancer research experience and has published over 40 peer-reviewed papers plus book chapters on the topics of molecular pathology and cytogenetic FISH technologies.

Dieter Peeters, MD, PhD

Dieter Peeters, MD, PhD

Dr. Peeters is a surgical pathologist who joined CellCarta in August 2018. He received his medical degree from the University of Antwerp in 2009 after which he obtained a PhD in Medical Sciences from the same university. His PhD research focused on the isolation and molecular characterization of circulating tumour cells (CTCs) in patients with metastatic breast cancer. Dr. Peeters has strong interests in oncopathology, immuno-oncology, molecular pathology and digital pathology, including imaging analysis. Apart from his work at CellCarta, Dr. Peeters also works as a surgical pathologist for a clinical laboratory that provides pathology services for three hospitals in the wider Antwerp area.

Monika Lamba Saini, MD, PhD

Monika Lamba Saini, MD, PhD

Dr. Saini is a pathologist-scientist with proven skills in microscopy and diagnosis of benign and malignant diseases of different organs, with special interests in thyroid, breast, and soft tissue. Her work at CellCarta includes histopathological evaluation of different cancers, evaluation of biomarkers related to immune-oncology therapies, providing pathology input for assay development, AI-based algorithms and digital image analyses. She is also the principal investigator and sub-investigator of trials, and supervisor of training programmes. Her research interests center on signal transduction pathways, cancer biology, immunobiology and digital pathology. She is a member of professional organizations like ASCO, EORTC Head and Neck Group, and ESMO. She is the author, co-author and peer reviewer of many national and international scientific publications, and an invited speaker at various international platforms.

Mary Schneck, MD

Mary Schneck, MD

Dr. Schneck began her CellCarta career in 2016 as a pathologist in Naperville, IL, USA. She attended the Perelman School of Medicine followed by residency training in Anatomic and Clinical Pathology at the University of Pennsylvania, where she also completed a fellowship in cytopathology. Mary received early training in immunohistochemistry as a Howard Hughes Medical Institute – NIH Research Scholar in the laboratory of Immunology and Tumor Biology at the NIH. Dr. Schneck went on to practice diagnostic surgical pathology and cytopathology for 27 years, with a special interest in gynecologic pathology, focusing on biomarker analysis and molecular pathology. She now dedicates her expertise to the discovery and validation of novel treatments as a CellCarta pathologist.

Diana Stanoeva, MD, PhD

Diana Stanoeva, MD, PhD

Dr. Stanoeva came to CellCarta from the diagnostic pathology world challenged by our professional role and the impact of the pharmaceutical industry on the growing need of new responsibilities of pathologists in a field which links larger collaboration, provides feedback on pre-analytic factors, quality assurance, and develops testing algorithms. It is a welcome work shift that allows her to play outside the routine pathology lab and inside oncology as a whole. She holds a PhD on placental changes in pathological pregnancies.

James Thompson, MD, PhD, Medical Director

James Thompson, MD, PhD, Medical Director

Dr. Thompson is a surgical and hematopathologist who is board certified in anatomic pathology. Dr. Thompson’s previous experience includes faculty positions at UC Irvine Medical School, Medical and Laboratory Director of Meyer Pharmaceuticals, Medical Director/Vice President of Technology Development at Impath, Medical Director of Oncotech, President and Medical Director of Pathogenesys, Medical Director of US LABS, Medical Director of Ambry Genetics, and Director of Hematopathology at Genoptix. Dr. Thompson obtained his undergraduate degree from University of California Irvine with his medical degree and doctorate in Microbiology and Molecular Genetics from University of California Irvine School of Medicine. He completed his pathology residency at the Stanford, with additional fellowship training in molecular pathology at Stanford and hematopathology at University of California Schools of Medicine.

Dino Vallera, MD

Dino Vallera, MD

Dr. Vallera attended the University of Chicago, and earned a bachelor’s degree in the Biological Sciences. He earned his medical degree at the University of Chicago’s Pritzker School of Medicine, where he also completed a residency in Anatomic and Clinical Pathology. Following residency, he completed a Fellowship in Cytopathology and Fine Needle Aspiration pathology at the University of Illinois Medical Center with Dr. Richard Mac DeMay. Dr. Vallera has been in private practice at AMITA Health Adventist Hinsdale and La Grange hospitals, Adventist Glen Oaks and Adventist Bolingbrook hospitals. He was the Regional Medical Director of the Adventist Midwest Laboratories from 2006 to 2019. He has also served in many leadership roles for the Medical Staff and was President of the Medical Staff (Chief of Staff) for AMITA Health Adventist Hinsdale and La Grange hospitals. Dr. Vallera was the medical director of the Quintiles Westmont Illinois laboratory from 2005 to 2012. He has also been a hospital and laboratory surveyor for the Joint Commission International.

Nathalie Van der Aa, MD, PhD

Pieter-Jan Van Dam, MD, PhD

Peter Vermeulen, MD, PhD, Surgical Pathologist

Peter Vermeulen, MD, PhD, Surgical Pathologist

Dr. Vermeulen spans histological and molecular technologies and has authored nearly 200 publications. Peter will lead our Patho-Imaging laboratory section and will also serve as a Principal Investigator for various studies. He is certified in multiple subspecialities and has deep clinical (especially breast cancer) and research (especially tumor vascularization) experience.

Walter Verstrepen, PhD

Wim Waelput, MD, PhD

Michael Yuan, MD

Michael Yuan, MD

Li-Jie Zhang, MD, PhD

Li-Jie Zhang, MD, PhD

Dr. Zhang completed her medical education at Beijing Medical University and Capital Medical University. She entered the pharmaceutical industry 12 years ago when a central lab set up the first anatomic pathology (AP) department in China. Dr. Zhang’s oncology drug development journey began with a breast cancer study, followed by various tumor studies including NSCLC, GC, CRC, UC, DLBCL, etc. as well as many companion diagnostic studies. The customers were top-30 global pharmaceutical companies with a gradual increasing presence of domestic Chinese companies.

Share

Careers

The best scientific minds working together to advance precision medicine

If you are passionate about science, join CellCarta and help shape the future of precision medicine.

See our job opportunities
Brandbourg_Caprion-1335-v2